Earnings Feed
Start Free
SALIX PHARMACEUTICALS LTD·4

Jul 5, 4:30 PM ET

LOGAN CAROLYN J 4

4 · SALIX PHARMACEUTICALS LTD · Filed Jul 5, 2012

Insider Transaction Report

Form 4
Period: 2012-07-02
SALIX PHARMACEUTICALS LTDSLXP
LOGAN CAROLYN J
DirectorPresident & CEO
Transactions
  • Tax Payment

    Common Stock

    2012-07-02$54.44/sh−17,357$944,915→ 627,131 total
Holdings

  • Common Stock

    (indirect: by GRAT)
    400,000

  • Option to Buy Common Stock

    Exercise: $17.63Exp: 2015-06-09→ Common Stock (44,000 underlying)
    44,000

  • Option to Buy Common Stock

    Exercise: $7.60Exp: 2013-07-24→ Common Stock (33,750 underlying)
    33,750

  • Option to Buy Common Stock

    Exercise: $18.87Exp: 2014-06-17→ Common Stock (33,750 underlying)
    33,750

  • Option to Buy Common Stock

    Exercise: $18.87Exp: 2014-06-17→ Common Stock (65,625 underlying)
    65,625
Footnotes (2)
  • [F1]Does not represent a sale in the market; represents a forfeiture of shares to the Issuer in order to pay tax withholding upon vesting of restricted stock.
  • [F2]Options are 100% vested.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION